Category Archives: TRIPS&IP rights

Better life through medicine—let’s leave no one behind

Source: http://www.thelancet.com The Lancet Commission on Essential Medicines Policies  rightfully addresses the need to guarantee access to essential medicines for all. However, we cannot achieve any real progress without acknowledging that the current patent-based business model and the way we … Continue reading

Posted in Delinkage, R&D, R&D, Sofosbuvir, TRIPS, TRIPS flexibilities, Uncategorized | Leave a comment

Pharmaceuticals & Patents, a talk by Justice Prabha Sridevan

  I am grateful to the Dr. N.S. Gopalakrishnan for inviting me to inaugurate this workshop, the theme being “Pharmaceuticals and patents.” This is a very important one today when there is a claim for a strong patent regime. But I must … Continue reading

Posted in Patent, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WTO | Leave a comment

Why RCEP is the problem, not the solution

Source: inquirer.net | May 17, 2017 On May 2-12, the 16 member-countries of the Regional Comprehensive Economic Partnership (RCEP) met in Manila for their 18th round of negotiations to craft a multilateral trade deal that would affect half of the world’s … Continue reading

Posted in Investor state dispute, IP Rights, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

Intellectual property, affordable medicine, and universal health care

By Dr. Maria Guevara, Business world online| May 05, 2017 MANILA IS SET to host the 18th round of the multilateral trade deal — the Regional Comprehensive Economic Partnership (RCEP) that encompasses 50% of the global population.  With the Philippines … Continue reading

Posted in IPR, Patent, Patents, Regional Comprehensive Economic Partnership, TPP, TRIPS, Uncategorized | Leave a comment

Oppose RCEP! Fight for Pro-People Trade!

People Over Profit Statement on the 18th Round of Negotiations of the Regional Comprehensive Economic Partnership (RCEP) in Manila, Philippines 10 May 2017 Amid growing dissent and discontent globally against neoliberal free trade and investment agreements (FTAs), trade negotiators from … Continue reading

Posted in ISDS, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Trade laws that rob common people

Dr Gopal Dabade, Deccan Herald|  May 8 2017 If the RCEP talks materialise, they will give big companies a market access to over 3 billion people. Trade between countries has existed since time immemorial. The World Tr­ade Organisation (WTO) is … Continue reading

Posted in Investor state dispute, IPR Enforcement, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, Uncategorized, WTO | Leave a comment

MSF response on RCEP negotiations in the Philippines

Source: MSF Access Campaign New Delhi, 8 May 2017 – The Philippines is set to host the 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement’s negotiations in Manila this week. Negotiators from the ten members of the … Continue reading

Posted in Data Exclusivity, Evergreening, Investor state dispute, IPR Enforcement, ISDS, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized, WTO | Leave a comment